Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studying the Dose Response of 50 and 100 IU of Botox A Toxin Injection in the Prostates of BPH Patients.

NCT02524236 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT02524236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02524236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studying the Dose Response of 50 and 100 IU of Botox A Toxin Injection in the Prostates of BPH Patients.
Lead sponsor
Beni-Suef University
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2015
Completion date
November 30, 2016
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia